PHARMACEUTICAL COMPOSITION CONTAINING URIDINE 5'-TRIPHOSPHATE FOR THE TREATMENT OF CYSTIC FIBROSIS

Uridine 5'-triphosphate, or a pharmaceutically acceptable salt thereof, is useful in the symptomatic treatment of cystic fibrosis when inhaled into the lungs. Suitable pharmaceutical compositions for use in such treatment include solutions for nebulization, non-pressurized powders and pressuriz...

Full description

Saved in:
Bibliographic Details
Main Authors JACKSON, DALE, MICHAEL, POLLARD, CHRISTOPHER, ERNEST
Format Patent
LanguageEnglish
Published 09.07.1992
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Uridine 5'-triphosphate, or a pharmaceutically acceptable salt thereof, is useful in the symptomatic treatment of cystic fibrosis when inhaled into the lungs. Suitable pharmaceutical compositions for use in such treatment include solutions for nebulization, non-pressurized powders and pressurized aerosols. L'uridine-5'-triphosphate, ou un sel pharmaceutiquement acceptable de celle-ci, est utile au traitement symptomatique de la mucoviscidose lorsqu'on l'aspire dans les poumons. Des compositions pharmaceutiques adaptées à ce traitement sont, par exemple, les solutions à nébuliser, les poudres non pressurisées et les aérosols sous pression.
Bibliography:Application Number: WO1991GB02299